T T-Detect

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark T T-Detect was filed as Figurative mark on 07/22/2021 at the World Intellectual Property Organization.

Logodesign (Wiener Klassifikation)

#Lines, bands #Letters presenting a special form of writing #Vertical lines or bands #Horizontal lines or bands

Trademark Details Last update: April 13, 2022

Trademark form Figurative mark
File reference 1628231
Countries Australia Canada China European Community United Kingdom Japan South Korea Mexico Turkey
Base trademark US No. 90481362, January 22, 2021
Application date July 22, 2021
Expiration date April 1, 2022

Trademark owner

1551 Eastlake Avenue E, Suite 200
Seattle WA 98102
US

Trademark representatives

310 East 4500 South Suite 400 Salt Lake City CA 84107 US

goods and services

05 Medical assay kits; medical immunosequencing-based assay kits; medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection
42 Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; medical laboratory immunosequencing-based services for analysis of biological samples
44 Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; providing medical immunosequencing-based testing for cancer, autoimmune disease and infection; consulting services in the field of medical immunosequencing-based testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories

Trademark history

Date Document number Area Entry
April 1, 2022 2022/15 Gaz RAW: Total Cancellation
March 16, 2022 2022/11 Gaz CN Rejection
March 3, 2022 2022/9 Gaz GB Rejection
February 9, 2022 2022/6 Gaz AU Rejection
July 22, 2021 2021/45 Gaz US Registration

ID: 141628231